Truist analyst Mark Hughes lowered the firm’s price target on Markel (MKL) to $1,950 from $2,100 and keeps a Hold rating on the shares. The firm cites the company’s below-consensus Q1 results as well as a lower assumed contribution from its non-insurance operations, also reducing its price target on multiple compression across the P&C carrier group, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKL:
- Markel Corporation’s Earnings and Capital at Risk Amid Escalating Geopolitical Tensions and Market Volatility
- Markel Group Q1 Call: Strong Core, Volatile Markets
- Markel reports Q1 revenue $3.55B, consensus $3.63B
- Jump collaborates with Markel, Joseph Caruso & Associates
- Markel Insurance launches PlayMicro in Canada
